nodes	percent_of_prediction	percent_of_DWPC	metapath
Epinastine—CYP2D6—breast cancer	0.139	0.389	CbGaD
Epinastine—CYP3A4—breast cancer	0.119	0.333	CbGaD
Epinastine—ABCB1—breast cancer	0.0991	0.278	CbGaD
Epinastine—CYP2B6—Thiotepa—breast cancer	0.0445	0.0943	CbGbCtD
Epinastine—CYP2B6—Raloxifene—breast cancer	0.0297	0.0629	CbGbCtD
Epinastine—ABCB1—Toremifene—breast cancer	0.0275	0.0584	CbGbCtD
Epinastine—CYP3A4—Exemestane—breast cancer	0.0238	0.0505	CbGbCtD
Epinastine—CYP2D6—Idarubicin—breast cancer	0.0215	0.0456	CbGbCtD
Epinastine—CYP3A4—Letrozole—breast cancer	0.0202	0.0429	CbGbCtD
Epinastine—ABCB1—Lapatinib—breast cancer	0.0201	0.0426	CbGbCtD
Epinastine—CYP2B6—Tamoxifen—breast cancer	0.0196	0.0416	CbGbCtD
Epinastine—CYP3A4—Anastrozole—breast cancer	0.018	0.0382	CbGbCtD
Epinastine—CYP3A4—Toremifene—breast cancer	0.0165	0.035	CbGbCtD
Epinastine—CYP3A4—Fulvestrant—breast cancer	0.0153	0.0325	CbGbCtD
Epinastine—CYP2B6—Irinotecan—breast cancer	0.0151	0.0319	CbGbCtD
Epinastine—CYP3A4—Thiotepa—breast cancer	0.0137	0.029	CbGbCtD
Epinastine—CYP3A4—Ixabepilone—breast cancer	0.0125	0.0265	CbGbCtD
Epinastine—CYP3A4—Lapatinib—breast cancer	0.012	0.0255	CbGbCtD
Epinastine—ABCB1—Vinorelbine—breast cancer	0.0111	0.0236	CbGbCtD
Epinastine—CYP2D6—Vinorelbine—breast cancer	0.0105	0.0223	CbGbCtD
Epinastine—ABCB1—Tamoxifen—breast cancer	0.01	0.0213	CbGbCtD
Epinastine—ABCB1—Mitoxantrone—breast cancer	0.0098	0.0208	CbGbCtD
Epinastine—CYP2D6—Tamoxifen—breast cancer	0.00947	0.0201	CbGbCtD
Epinastine—CYP3A4—Raloxifene—breast cancer	0.00911	0.0193	CbGbCtD
Epinastine—ABCB1—Gemcitabine—breast cancer	0.00866	0.0184	CbGbCtD
Epinastine—CYP2B6—Doxorubicin—breast cancer	0.00822	0.0174	CbGbCtD
Epinastine—ABCB1—Paclitaxel—breast cancer	0.00782	0.0166	CbGbCtD
Epinastine—ABCB1—Irinotecan—breast cancer	0.00772	0.0164	CbGbCtD
Epinastine—ABCB1—Vinblastine—breast cancer	0.00686	0.0146	CbGbCtD
Epinastine—CYP3A4—Vinorelbine—breast cancer	0.00667	0.0142	CbGbCtD
Epinastine—CYP2D6—Vinblastine—breast cancer	0.00646	0.0137	CbGbCtD
Epinastine—CYP3A4—Tamoxifen—breast cancer	0.00602	0.0128	CbGbCtD
Epinastine—CYP3A4—Mitoxantrone—breast cancer	0.00587	0.0125	CbGbCtD
Epinastine—ABCB1—Docetaxel—breast cancer	0.00565	0.012	CbGbCtD
Epinastine—CYP3A4—Paclitaxel—breast cancer	0.00469	0.00994	CbGbCtD
Epinastine—CYP3A4—Irinotecan—breast cancer	0.00462	0.00981	CbGbCtD
Epinastine—ABCB1—Doxorubicin—breast cancer	0.00422	0.00894	CbGbCtD
Epinastine—CYP3A4—Vinblastine—breast cancer	0.00411	0.00872	CbGbCtD
Epinastine—ABCB1—Methotrexate—breast cancer	0.00408	0.00866	CbGbCtD
Epinastine—CYP2D6—Doxorubicin—breast cancer	0.00397	0.00843	CbGbCtD
Epinastine—CYP3A4—Docetaxel—breast cancer	0.00339	0.00719	CbGbCtD
Epinastine—CYP3A4—Doxorubicin—breast cancer	0.00253	0.00536	CbGbCtD
Epinastine—Cough increased—Fulvestrant—breast cancer	0.00236	0.0291	CcSEcCtD
Epinastine—Eye irritation—Letrozole—breast cancer	0.00195	0.0241	CcSEcCtD
Epinastine—Lacrimation increased—Ixabepilone—breast cancer	0.00192	0.0237	CcSEcCtD
Epinastine—Cough increased—Anastrozole—breast cancer	0.00182	0.0225	CcSEcCtD
Epinastine—Cough increased—Raloxifene—breast cancer	0.00173	0.0213	CcSEcCtD
Epinastine—Cough increased—Tamoxifen—breast cancer	0.00124	0.0154	CcSEcCtD
Epinastine—Cough increased—Goserelin—breast cancer	0.00119	0.0147	CcSEcCtD
Epinastine—Upper respiratory tract infection—Exemestane—breast cancer	0.00109	0.0135	CcSEcCtD
Epinastine—Pharyngitis—Fulvestrant—breast cancer	0.00108	0.0133	CcSEcCtD
Epinastine—Upper respiratory tract infection—Ixabepilone—breast cancer	0.00103	0.0127	CcSEcCtD
Epinastine—Sinusitis—Exemestane—breast cancer	0.000984	0.0122	CcSEcCtD
Epinastine—Rhinitis—Exemestane—breast cancer	0.000943	0.0117	CcSEcCtD
Epinastine—Pharyngitis—Exemestane—breast cancer	0.000934	0.0115	CcSEcCtD
Epinastine—Eye irritation—Fluorouracil—breast cancer	0.000902	0.0111	CcSEcCtD
Epinastine—Cough—Lapatinib—breast cancer	0.000895	0.0111	CcSEcCtD
Epinastine—Infection—Carboplatin—breast cancer	0.000882	0.0109	CcSEcCtD
Epinastine—Cough increased—Irinotecan—breast cancer	0.000878	0.0109	CcSEcCtD
Epinastine—Sinusitis—Anastrozole—breast cancer	0.000874	0.0108	CcSEcCtD
Epinastine—Lacrimation increased—Irinotecan—breast cancer	0.000872	0.0108	CcSEcCtD
Epinastine—Rhinitis—Anastrozole—breast cancer	0.000838	0.0104	CcSEcCtD
Epinastine—Lacrimation increased—Fluorouracil—breast cancer	0.000835	0.0103	CcSEcCtD
Epinastine—Infection—Lapatinib—breast cancer	0.000832	0.0103	CcSEcCtD
Epinastine—Pharyngitis—Anastrozole—breast cancer	0.00083	0.0103	CcSEcCtD
Epinastine—Sinusitis—Raloxifene—breast cancer	0.000829	0.0103	CcSEcCtD
Epinastine—Cough—Fulvestrant—breast cancer	0.000823	0.0102	CcSEcCtD
Epinastine—Rhinitis—Raloxifene—breast cancer	0.000796	0.00984	CcSEcCtD
Epinastine—Pharyngitis—Raloxifene—breast cancer	0.000788	0.00974	CcSEcCtD
Epinastine—Eye irritation—Paclitaxel—breast cancer	0.000768	0.00949	CcSEcCtD
Epinastine—Infection—Fulvestrant—breast cancer	0.000765	0.00946	CcSEcCtD
Epinastine—Headache—Fluoxymesterone—breast cancer	0.000739	0.00913	CcSEcCtD
Epinastine—Cough—Exemestane—breast cancer	0.000715	0.00884	CcSEcCtD
Epinastine—Lacrimation increased—Paclitaxel—breast cancer	0.000711	0.0088	CcSEcCtD
Epinastine—HRH2—skin of body—breast cancer	0.000681	0.0545	CbGeAlD
Epinastine—Cough—Ixabepilone—breast cancer	0.000675	0.00834	CcSEcCtD
Epinastine—Infection—Exemestane—breast cancer	0.000664	0.00821	CcSEcCtD
Epinastine—Eye irritation—Docetaxel—breast cancer	0.000651	0.00805	CcSEcCtD
Epinastine—Cough—Letrozole—breast cancer	0.000635	0.00785	CcSEcCtD
Epinastine—Cough—Anastrozole—breast cancer	0.000635	0.00785	CcSEcCtD
Epinastine—Upper respiratory tract infection—Goserelin—breast cancer	0.000635	0.00785	CcSEcCtD
Epinastine—Eye irritation—Capecitabine—breast cancer	0.00063	0.00779	CcSEcCtD
Epinastine—Infection—Ixabepilone—breast cancer	0.000627	0.00775	CcSEcCtD
Epinastine—Lacrimation increased—Docetaxel—breast cancer	0.000603	0.00746	CcSEcCtD
Epinastine—Cough—Raloxifene—breast cancer	0.000603	0.00745	CcSEcCtD
Epinastine—Sinusitis—Tamoxifen—breast cancer	0.000598	0.00739	CcSEcCtD
Epinastine—Pruritus—Lapatinib—breast cancer	0.000592	0.00732	CcSEcCtD
Epinastine—Infection—Letrozole—breast cancer	0.00059	0.0073	CcSEcCtD
Epinastine—Infection—Anastrozole—breast cancer	0.00059	0.0073	CcSEcCtD
Epinastine—Pharyngitis—Vinblastine—breast cancer	0.000585	0.00723	CcSEcCtD
Epinastine—Lacrimation increased—Capecitabine—breast cancer	0.000584	0.00722	CcSEcCtD
Epinastine—Sinusitis—Goserelin—breast cancer	0.000571	0.00706	CcSEcCtD
Epinastine—Pharyngitis—Tamoxifen—breast cancer	0.000568	0.00702	CcSEcCtD
Epinastine—Infection—Raloxifene—breast cancer	0.00056	0.00693	CcSEcCtD
Epinastine—Infection—Idarubicin—breast cancer	0.00056	0.00693	CcSEcCtD
Epinastine—Rhinitis—Goserelin—breast cancer	0.000548	0.00678	CcSEcCtD
Epinastine—Pruritus—Fulvestrant—breast cancer	0.000545	0.00673	CcSEcCtD
Epinastine—Pharyngitis—Goserelin—breast cancer	0.000542	0.00671	CcSEcCtD
Epinastine—Pruritus—Toremifene—breast cancer	0.000538	0.00665	CcSEcCtD
Epinastine—Headache—Lapatinib—breast cancer	0.000524	0.00648	CcSEcCtD
Epinastine—HRH2—adrenal gland—breast cancer	0.000519	0.0416	CbGeAlD
Epinastine—Nasopharyngitis—Fluorouracil—breast cancer	0.0005	0.00618	CcSEcCtD
Epinastine—Headache—Fulvestrant—breast cancer	0.000482	0.00596	CcSEcCtD
Epinastine—Headache—Toremifene—breast cancer	0.000476	0.00589	CcSEcCtD
Epinastine—Pruritus—Exemestane—breast cancer	0.000473	0.00585	CcSEcCtD
Epinastine—Upper respiratory tract infection—Irinotecan—breast cancer	0.000469	0.0058	CcSEcCtD
Epinastine—Upper respiratory tract infection—Mitoxantrone—breast cancer	0.000469	0.0058	CcSEcCtD
Epinastine—Infection—Chlorambucil—breast cancer	0.000454	0.00561	CcSEcCtD
Epinastine—HRH2—endocrine gland—breast cancer	0.00045	0.036	CbGeAlD
Epinastine—Upper respiratory tract infection—Fluorouracil—breast cancer	0.000449	0.00555	CcSEcCtD
Epinastine—Pruritus—Ixabepilone—breast cancer	0.000446	0.00552	CcSEcCtD
Epinastine—Cough—Tamoxifen—breast cancer	0.000435	0.00537	CcSEcCtD
Epinastine—Cough—Melphalan—breast cancer	0.000426	0.00526	CcSEcCtD
Epinastine—Nasopharyngitis—Paclitaxel—breast cancer	0.000426	0.00526	CcSEcCtD
Epinastine—Sinusitis—Mitoxantrone—breast cancer	0.000422	0.00522	CcSEcCtD
Epinastine—Pruritus—Letrozole—breast cancer	0.00042	0.0052	CcSEcCtD
Epinastine—Pruritus—Anastrozole—breast cancer	0.00042	0.0052	CcSEcCtD
Epinastine—Headache—Exemestane—breast cancer	0.000419	0.00518	CcSEcCtD
Epinastine—Cough—Goserelin—breast cancer	0.000415	0.00513	CcSEcCtD
Epinastine—Cough increased—Epirubicin—breast cancer	0.000409	0.00506	CcSEcCtD
Epinastine—Lacrimation increased—Epirubicin—breast cancer	0.000407	0.00503	CcSEcCtD
Epinastine—Rhinitis—Irinotecan—breast cancer	0.000405	0.005	CcSEcCtD
Epinastine—Rhinitis—Mitoxantrone—breast cancer	0.000405	0.005	CcSEcCtD
Epinastine—Sinusitis—Fluorouracil—breast cancer	0.000404	0.005	CcSEcCtD
Epinastine—Infection—Tamoxifen—breast cancer	0.000404	0.00499	CcSEcCtD
Epinastine—HRH1—nipple—breast cancer	0.000404	0.0323	CbGeAlD
Epinastine—Pharyngitis—Mitoxantrone—breast cancer	0.000401	0.00495	CcSEcCtD
Epinastine—ADRA2A—nipple—breast cancer	0.000397	0.0318	CbGeAlD
Epinastine—Infection—Melphalan—breast cancer	0.000395	0.00489	CcSEcCtD
Epinastine—Headache—Ixabepilone—breast cancer	0.000395	0.00489	CcSEcCtD
Epinastine—Rhinitis—Gemcitabine—breast cancer	0.000394	0.00488	CcSEcCtD
Epinastine—Pharyngitis—Gemcitabine—breast cancer	0.00039	0.00483	CcSEcCtD
Epinastine—Rhinitis—Fluorouracil—breast cancer	0.000388	0.00479	CcSEcCtD
Epinastine—Infection—Goserelin—breast cancer	0.000386	0.00477	CcSEcCtD
Epinastine—Pharyngitis—Fluorouracil—breast cancer	0.000384	0.00475	CcSEcCtD
Epinastine—Upper respiratory tract infection—Paclitaxel—breast cancer	0.000382	0.00473	CcSEcCtD
Epinastine—Cough increased—Doxorubicin—breast cancer	0.000379	0.00468	CcSEcCtD
Epinastine—Lacrimation increased—Doxorubicin—breast cancer	0.000376	0.00465	CcSEcCtD
Epinastine—Headache—Anastrozole—breast cancer	0.000372	0.0046	CcSEcCtD
Epinastine—Headache—Letrozole—breast cancer	0.000372	0.0046	CcSEcCtD
Epinastine—Cough—Vinorelbine—breast cancer	0.000372	0.0046	CcSEcCtD
Epinastine—HTR7—epithelium—breast cancer	0.000364	0.0292	CbGeAlD
Epinastine—Nasopharyngitis—Docetaxel—breast cancer	0.000361	0.00446	CcSEcCtD
Epinastine—Cough—Thiotepa—breast cancer	0.000355	0.00439	CcSEcCtD
Epinastine—Headache—Idarubicin—breast cancer	0.000353	0.00437	CcSEcCtD
Epinastine—Headache—Raloxifene—breast cancer	0.000353	0.00437	CcSEcCtD
Epinastine—ADRA1A—epithelium—breast cancer	0.000351	0.0281	CbGeAlD
Epinastine—Nasopharyngitis—Capecitabine—breast cancer	0.000349	0.00432	CcSEcCtD
Epinastine—Infection—Vinorelbine—breast cancer	0.000345	0.00427	CcSEcCtD
Epinastine—Sinusitis—Paclitaxel—breast cancer	0.000344	0.00425	CcSEcCtD
Epinastine—Rhinitis—Paclitaxel—breast cancer	0.00033	0.00408	CcSEcCtD
Epinastine—Infection—Thiotepa—breast cancer	0.00033	0.00408	CcSEcCtD
Epinastine—Pharyngitis—Paclitaxel—breast cancer	0.000327	0.00404	CcSEcCtD
Epinastine—Pruritus—Chlorambucil—breast cancer	0.000323	0.004	CcSEcCtD
Epinastine—Upper respiratory tract infection—Capecitabine—breast cancer	0.000314	0.00388	CcSEcCtD
Epinastine—HRH2—lymph node—breast cancer	0.000311	0.0249	CbGeAlD
Epinastine—Cough—Mitoxantrone—breast cancer	0.000307	0.00379	CcSEcCtD
Epinastine—Cough—Irinotecan—breast cancer	0.000307	0.00379	CcSEcCtD
Epinastine—Cough—Gemcitabine—breast cancer	0.000299	0.00369	CcSEcCtD
Epinastine—Pruritus—Tamoxifen—breast cancer	0.000288	0.00356	CcSEcCtD
Epinastine—Infection—Mitoxantrone—breast cancer	0.000285	0.00352	CcSEcCtD
Epinastine—Infection—Irinotecan—breast cancer	0.000285	0.00352	CcSEcCtD
Epinastine—ADRA1A—adipose tissue—breast cancer	0.000284	0.0227	CbGeAlD
Epinastine—Pruritus—Melphalan—breast cancer	0.000282	0.00348	CcSEcCtD
Epinastine—Rhinitis—Docetaxel—breast cancer	0.00028	0.00346	CcSEcCtD
Epinastine—HTR2A—embryo—breast cancer	0.000278	0.0223	CbGeAlD
Epinastine—Infection—Gemcitabine—breast cancer	0.000278	0.00343	CcSEcCtD
Epinastine—Pharyngitis—Docetaxel—breast cancer	0.000277	0.00342	CcSEcCtD
Epinastine—Pruritus—Goserelin—breast cancer	0.000275	0.0034	CcSEcCtD
Epinastine—Infection—Fluorouracil—breast cancer	0.000273	0.00337	CcSEcCtD
Epinastine—HRH1—epithelium—breast cancer	0.000272	0.0218	CbGeAlD
Epinastine—Rhinitis—Capecitabine—breast cancer	0.000271	0.00335	CcSEcCtD
Epinastine—HTR7—female reproductive system—breast cancer	0.000271	0.0217	CbGeAlD
Epinastine—Pharyngitis—Capecitabine—breast cancer	0.000268	0.00332	CcSEcCtD
Epinastine—CYP2B6—skin of body—breast cancer	0.000265	0.0212	CbGeAlD
Epinastine—HTR7—adrenal gland—breast cancer	0.000264	0.0211	CbGeAlD
Epinastine—Headache—Vinblastine—breast cancer	0.000262	0.00324	CcSEcCtD
Epinastine—Headache—Tamoxifen—breast cancer	0.000255	0.00315	CcSEcCtD
Epinastine—ADRA1A—adrenal gland—breast cancer	0.000255	0.0204	CbGeAlD
Epinastine—Cough—Paclitaxel—breast cancer	0.00025	0.00309	CcSEcCtD
Epinastine—Pruritus—Vinorelbine—breast cancer	0.000246	0.00304	CcSEcCtD
Epinastine—HRH1—endometrium—breast cancer	0.000244	0.0195	CbGeAlD
Epinastine—Nasopharyngitis—Epirubicin—breast cancer	0.000243	0.00301	CcSEcCtD
Epinastine—Headache—Goserelin—breast cancer	0.000243	0.00301	CcSEcCtD
Epinastine—ADRA2A—endometrium—breast cancer	0.000239	0.0192	CbGeAlD
Epinastine—Pruritus—Thiotepa—breast cancer	0.000235	0.00291	CcSEcCtD
Epinastine—Upper respiratory tract infection—Methotrexate—breast cancer	0.000234	0.00289	CcSEcCtD
Epinastine—Infection—Paclitaxel—breast cancer	0.000232	0.00287	CcSEcCtD
Epinastine—HTR7—endocrine gland—breast cancer	0.000229	0.0183	CbGeAlD
Epinastine—HTR2A—epithelium—breast cancer	0.000227	0.0182	CbGeAlD
Epinastine—Nasopharyngitis—Doxorubicin—breast cancer	0.000225	0.00278	CcSEcCtD
Epinastine—ADRA1A—endocrine gland—breast cancer	0.000221	0.0177	CbGeAlD
Epinastine—ADRA2A—uterus—breast cancer	0.000221	0.0177	CbGeAlD
Epinastine—HRH1—adipose tissue—breast cancer	0.00022	0.0176	CbGeAlD
Epinastine—Upper respiratory tract infection—Epirubicin—breast cancer	0.000219	0.0027	CcSEcCtD
Epinastine—Headache—Vinorelbine—breast cancer	0.000218	0.00269	CcSEcCtD
Epinastine—ADRA2A—pituitary gland—breast cancer	0.000217	0.0173	CbGeAlD
Epinastine—ADRA2A—adipose tissue—breast cancer	0.000216	0.0173	CbGeAlD
Epinastine—Cough—Docetaxel—breast cancer	0.000212	0.00262	CcSEcCtD
Epinastine—Headache—Thiotepa—breast cancer	0.000208	0.00257	CcSEcCtD
Epinastine—CYP2B6—female reproductive system—breast cancer	0.000207	0.0166	CbGeAlD
Epinastine—Cough—Capecitabine—breast cancer	0.000205	0.00254	CcSEcCtD
Epinastine—Upper respiratory tract infection—Doxorubicin—breast cancer	0.000202	0.0025	CcSEcCtD
Epinastine—HRH1—female reproductive system—breast cancer	0.000202	0.0162	CbGeAlD
Epinastine—CYP2B6—adrenal gland—breast cancer	0.000202	0.0162	CbGeAlD
Epinastine—Pharyngitis—Methotrexate—breast cancer	0.0002	0.00247	CcSEcCtD
Epinastine—ADRA2A—female reproductive system—breast cancer	0.000198	0.0159	CbGeAlD
Epinastine—Pruritus—Gemcitabine—breast cancer	0.000198	0.00244	CcSEcCtD
Epinastine—HRH1—adrenal gland—breast cancer	0.000197	0.0158	CbGeAlD
Epinastine—Infection—Docetaxel—breast cancer	0.000197	0.00244	CcSEcCtD
Epinastine—Sinusitis—Epirubicin—breast cancer	0.000197	0.00243	CcSEcCtD
Epinastine—Pruritus—Fluorouracil—breast cancer	0.000194	0.0024	CcSEcCtD
Epinastine—ADRA2A—adrenal gland—breast cancer	0.000194	0.0155	CbGeAlD
Epinastine—Infection—Capecitabine—breast cancer	0.000191	0.00236	CcSEcCtD
Epinastine—Rhinitis—Epirubicin—breast cancer	0.000189	0.00233	CcSEcCtD
Epinastine—Pharyngitis—Epirubicin—breast cancer	0.000187	0.00231	CcSEcCtD
Epinastine—HTR2A—pituitary gland—breast cancer	0.000184	0.0148	CbGeAlD
Epinastine—HRH1—female gonad—breast cancer	0.000184	0.0147	CbGeAlD
Epinastine—ABCB1—embryo—breast cancer	0.000182	0.0146	CbGeAlD
Epinastine—Sinusitis—Doxorubicin—breast cancer	0.000182	0.00225	CcSEcCtD
Epinastine—ADRA2A—female gonad—breast cancer	0.000181	0.0145	CbGeAlD
Epinastine—Headache—Mitoxantrone—breast cancer	0.00018	0.00222	CcSEcCtD
Epinastine—Headache—Irinotecan—breast cancer	0.00018	0.00222	CcSEcCtD
Epinastine—Headache—Gemcitabine—breast cancer	0.000175	0.00216	CcSEcCtD
Epinastine—CYP2B6—endocrine gland—breast cancer	0.000175	0.014	CbGeAlD
Epinastine—Rhinitis—Doxorubicin—breast cancer	0.000175	0.00216	CcSEcCtD
Epinastine—Pharyngitis—Doxorubicin—breast cancer	0.000173	0.00214	CcSEcCtD
Epinastine—Headache—Fluorouracil—breast cancer	0.000172	0.00213	CcSEcCtD
Epinastine—HRH1—endocrine gland—breast cancer	0.000171	0.0137	CbGeAlD
Epinastine—HTR2A—female reproductive system—breast cancer	0.000169	0.0135	CbGeAlD
Epinastine—ADRA2A—endocrine gland—breast cancer	0.000168	0.0134	CbGeAlD
Epinastine—Pruritus—Paclitaxel—breast cancer	0.000165	0.00205	CcSEcCtD
Epinastine—HTR2A—adrenal gland—breast cancer	0.000165	0.0132	CbGeAlD
Epinastine—CYP3A4—female reproductive system—breast cancer	0.000156	0.0125	CbGeAlD
Epinastine—CYP2D6—female reproductive system—breast cancer	0.000154	0.0123	CbGeAlD
Epinastine—Cough—Methotrexate—breast cancer	0.000153	0.00189	CcSEcCtD
Epinastine—ABCB1—epithelium—breast cancer	0.000149	0.0119	CbGeAlD
Epinastine—Headache—Paclitaxel—breast cancer	0.000147	0.00181	CcSEcCtD
Epinastine—Cough—Epirubicin—breast cancer	0.000143	0.00177	CcSEcCtD
Epinastine—HTR2A—endocrine gland—breast cancer	0.000143	0.0114	CbGeAlD
Epinastine—Infection—Methotrexate—breast cancer	0.000142	0.00176	CcSEcCtD
Epinastine—Pruritus—Docetaxel—breast cancer	0.00014	0.00173	CcSEcCtD
Epinastine—CYP2D6—female gonad—breast cancer	0.00014	0.0112	CbGeAlD
Epinastine—Oxcarbazepine—CYP3A4—breast cancer	0.000137	0.0682	CrCbGaD
Epinastine—Mirtazapine—CYP2D6—breast cancer	0.000137	0.068	CrCbGaD
Epinastine—Pruritus—Capecitabine—breast cancer	0.000136	0.00168	CcSEcCtD
Epinastine—ABCB1—endometrium—breast cancer	0.000133	0.0107	CbGeAlD
Epinastine—Infection—Epirubicin—breast cancer	0.000133	0.00164	CcSEcCtD
Epinastine—Cough—Doxorubicin—breast cancer	0.000132	0.00164	CcSEcCtD
Epinastine—CYP3A4—endocrine gland—breast cancer	0.000132	0.0106	CbGeAlD
Epinastine—Nortriptyline—PTGS1—breast cancer	0.000132	0.0656	CrCbGaD
Epinastine—CYP2D6—endocrine gland—breast cancer	0.00013	0.0104	CbGeAlD
Epinastine—Headache—Docetaxel—breast cancer	0.000124	0.00154	CcSEcCtD
Epinastine—ABCB1—uterus—breast cancer	0.000123	0.00984	CbGeAlD
Epinastine—Infection—Doxorubicin—breast cancer	0.000123	0.00152	CcSEcCtD
Epinastine—ABCB1—pituitary gland—breast cancer	0.000121	0.00967	CbGeAlD
Epinastine—ABCB1—adipose tissue—breast cancer	0.00012	0.00963	CbGeAlD
Epinastine—Headache—Capecitabine—breast cancer	0.00012	0.00149	CcSEcCtD
Epinastine—Oxcarbazepine—ALB—breast cancer	0.00012	0.0595	CrCbGaD
Epinastine—HRH1—lymph node—breast cancer	0.000118	0.00946	CbGeAlD
Epinastine—Mirtazapine—CYP3A4—breast cancer	0.000117	0.0583	CrCbGaD
Epinastine—ADRA2A—lymph node—breast cancer	0.000116	0.00929	CbGeAlD
Epinastine—ABCB1—female reproductive system—breast cancer	0.000111	0.00885	CbGeAlD
Epinastine—ABCB1—adrenal gland—breast cancer	0.000108	0.00864	CbGeAlD
Epinastine—ABCB1—bone marrow—breast cancer	0.000104	0.00835	CbGeAlD
Epinastine—Pruritus—Methotrexate—breast cancer	0.000101	0.00125	CcSEcCtD
Epinastine—ABCB1—female gonad—breast cancer	0.000101	0.00805	CbGeAlD
Epinastine—Mianserin—CYP2D6—breast cancer	0.000101	0.05	CrCbGaD
Epinastine—Pruritus—Epirubicin—breast cancer	9.46e-05	0.00117	CcSEcCtD
Epinastine—Carbamazepine—CYP3A4—breast cancer	9.36e-05	0.0465	CrCbGaD
Epinastine—ABCB1—endocrine gland—breast cancer	9.35e-05	0.00749	CbGeAlD
Epinastine—Nortriptyline—CYP2D6—breast cancer	8.98e-05	0.0447	CrCbGaD
Epinastine—Headache—Methotrexate—breast cancer	8.95e-05	0.00111	CcSEcCtD
Epinastine—Pruritus—Doxorubicin—breast cancer	8.75e-05	0.00108	CcSEcCtD
Epinastine—Mianserin—CYP3A4—breast cancer	8.62e-05	0.0429	CrCbGaD
Epinastine—Trimipramine—CYP2D6—breast cancer	8.46e-05	0.042	CrCbGaD
Epinastine—Headache—Epirubicin—breast cancer	8.38e-05	0.00104	CcSEcCtD
Epinastine—Carbamazepine—ABCB1—breast cancer	7.79e-05	0.0387	CrCbGaD
Epinastine—Headache—Doxorubicin—breast cancer	7.75e-05	0.000959	CcSEcCtD
Epinastine—Nortriptyline—CYP3A4—breast cancer	7.71e-05	0.0383	CrCbGaD
Epinastine—Desipramine—CYP2D6—breast cancer	7.4e-05	0.0368	CrCbGaD
Epinastine—Trimipramine—CYP3A4—breast cancer	7.26e-05	0.0361	CrCbGaD
Epinastine—Nortriptyline—ALB—breast cancer	6.72e-05	0.0334	CrCbGaD
Epinastine—ABCB1—lymph node—breast cancer	6.47e-05	0.00518	CbGeAlD
Epinastine—Desipramine—CYP3A4—breast cancer	6.34e-05	0.0315	CrCbGaD
Epinastine—Imipramine—CYP2D6—breast cancer	6.27e-05	0.0312	CrCbGaD
Epinastine—Amitriptyline—CYP2D6—breast cancer	6.23e-05	0.031	CrCbGaD
Epinastine—Trimipramine—ABCB1—breast cancer	6.04e-05	0.03	CrCbGaD
Epinastine—Imipramine—CYP3A4—breast cancer	5.38e-05	0.0267	CrCbGaD
Epinastine—Amitriptyline—CYP3A4—breast cancer	5.35e-05	0.0266	CrCbGaD
Epinastine—Desipramine—ABCB1—breast cancer	5.28e-05	0.0263	CrCbGaD
Epinastine—Amitriptyline—ALB—breast cancer	4.66e-05	0.0232	CrCbGaD
Epinastine—Imipramine—ABCB1—breast cancer	4.48e-05	0.0223	CrCbGaD
Epinastine—Amitriptyline—ABCB1—breast cancer	4.45e-05	0.0221	CrCbGaD
Epinastine—CYP2B6—Metabolism—PIK3CD—breast cancer	3.34e-06	4.36e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—IGF1—breast cancer	3.34e-06	4.36e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—AKT2—breast cancer	3.33e-06	4.36e-05	CbGpPWpGaD
Epinastine—ABCB1—Metabolism—MTHFR—breast cancer	3.33e-06	4.36e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling by GPCR—EGFR—breast cancer	3.32e-06	4.34e-05	CbGpPWpGaD
Epinastine—CYP2B6—Metabolism—ALB—breast cancer	3.29e-06	4.31e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—NCOA2—breast cancer	3.29e-06	4.3e-05	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—MAPK3—breast cancer	3.29e-06	4.3e-05	CbGpPWpGaD
Epinastine—HRH2—Signaling Pathways—HRAS—breast cancer	3.28e-06	4.29e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—PIK3CD—breast cancer	3.27e-06	4.28e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—PIK3CD—breast cancer	3.26e-06	4.27e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling by GPCR—MAPK3—breast cancer	3.24e-06	4.24e-05	CbGpPWpGaD
Epinastine—HTR2A—GPCR downstream signaling—PIK3CA—breast cancer	3.24e-06	4.24e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—SERPINE1—breast cancer	3.23e-06	4.23e-05	CbGpPWpGaD
Epinastine—HRH1—GPCR downstream signaling—PIK3CA—breast cancer	3.23e-06	4.23e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—SERPINE1—breast cancer	3.23e-06	4.22e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—PIK3CD—breast cancer	3.2e-06	4.19e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling by GPCR—KRAS—breast cancer	3.2e-06	4.19e-05	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—MYC—breast cancer	3.2e-06	4.18e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling by GPCR—KRAS—breast cancer	3.19e-06	4.18e-05	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—TGFB1—breast cancer	3.19e-06	4.17e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—FASN—breast cancer	3.19e-06	4.17e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—BRAF—breast cancer	3.18e-06	4.16e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—BCHE—breast cancer	3.18e-06	4.15e-05	CbGpPWpGaD
Epinastine—ADRA1A—GPCR downstream signaling—PIK3CA—breast cancer	3.17e-06	4.15e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—SERPINE1—breast cancer	3.17e-06	4.14e-05	CbGpPWpGaD
Epinastine—CYP2B6—Metabolism—NOS3—breast cancer	3.15e-06	4.12e-05	CbGpPWpGaD
Epinastine—CYP2D6—Metabolism—MTHFR—breast cancer	3.14e-06	4.1e-05	CbGpPWpGaD
Epinastine—HRH2—Signaling Pathways—IL6—breast cancer	3.14e-06	4.1e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—SLC5A5—breast cancer	3.14e-06	4.1e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling by GPCR—KRAS—breast cancer	3.13e-06	4.1e-05	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—EGFR—breast cancer	3.13e-06	4.09e-05	CbGpPWpGaD
Epinastine—ADRA2A—Metabolism—PIK3CB—breast cancer	3.1e-06	4.05e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—IGF1—breast cancer	3.1e-06	4.05e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—AKT2—breast cancer	3.1e-06	4.05e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—NOS3—breast cancer	3.09e-06	4.04e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling by GPCR—EGFR—breast cancer	3.08e-06	4.03e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—NOS3—breast cancer	3.08e-06	4.03e-05	CbGpPWpGaD
Epinastine—ADRA2A—Metabolism—PTGS2—breast cancer	3.07e-06	4.02e-05	CbGpPWpGaD
Epinastine—ABCB1—Metabolism—CAV1—breast cancer	3.07e-06	4.02e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—NQO1—breast cancer	3.03e-06	3.96e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—SLC2A1—breast cancer	3.03e-06	3.96e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—NOS3—breast cancer	3.02e-06	3.95e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—PIK3CD—breast cancer	2.98e-06	3.89e-05	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—KRAS—breast cancer	2.95e-06	3.86e-05	CbGpPWpGaD
Epinastine—ADRA2A—GPCR downstream signaling—PIK3CA—breast cancer	2.95e-06	3.85e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—SERPINE1—breast cancer	2.94e-06	3.85e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling by GPCR—PIK3CA—breast cancer	2.94e-06	3.85e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling by GPCR—PIK3CA—breast cancer	2.94e-06	3.84e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—MDM2—breast cancer	2.93e-06	3.83e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—MDM2—breast cancer	2.92e-06	3.82e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—RAF1—breast cancer	2.92e-06	3.82e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—RAF1—breast cancer	2.91e-06	3.81e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling by GPCR—KRAS—breast cancer	2.91e-06	3.81e-05	CbGpPWpGaD
Epinastine—CYP2B6—Metabolism—PIK3CB—breast cancer	2.91e-06	3.8e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—RELA—breast cancer	2.91e-06	3.8e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—CYP1B1—breast cancer	2.9e-06	3.8e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—RELA—breast cancer	2.9e-06	3.79e-05	CbGpPWpGaD
Epinastine—CYP2D6—Metabolism—CAV1—breast cancer	2.9e-06	3.79e-05	CbGpPWpGaD
Epinastine—HRH2—Signaling Pathways—AKT1—breast cancer	2.89e-06	3.78e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—ERBB2—breast cancer	2.89e-06	3.78e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—ERBB2—breast cancer	2.88e-06	3.77e-05	CbGpPWpGaD
Epinastine—CYP2B6—Metabolism—PTGS2—breast cancer	2.88e-06	3.77e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling by GPCR—PIK3CA—breast cancer	2.88e-06	3.77e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—MDM2—breast cancer	2.87e-06	3.75e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—RAF1—breast cancer	2.86e-06	3.74e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—PIK3CB—breast cancer	2.85e-06	3.73e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—MTOR—breast cancer	2.85e-06	3.73e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—HSP90AA1—breast cancer	2.85e-06	3.72e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—RELA—breast cancer	2.85e-06	3.72e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—MTOR—breast cancer	2.84e-06	3.72e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—PIK3CB—breast cancer	2.84e-06	3.72e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—ERBB2—breast cancer	2.83e-06	3.7e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—NOS3—breast cancer	2.81e-06	3.67e-05	CbGpPWpGaD
Epinastine—ABCB1—Metabolism—PIK3CG—breast cancer	2.8e-06	3.66e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—PIK3CB—breast cancer	2.79e-06	3.65e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—MTOR—breast cancer	2.79e-06	3.65e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—NCOA1—breast cancer	2.77e-06	3.62e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—CXCL8—breast cancer	2.74e-06	3.58e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—CXCL8—breast cancer	2.73e-06	3.57e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—STK11—breast cancer	2.73e-06	3.57e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—CYP19A1—breast cancer	2.73e-06	3.57e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling by GPCR—HRAS—breast cancer	2.72e-06	3.56e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling by GPCR—HRAS—breast cancer	2.72e-06	3.55e-05	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—PIK3CA—breast cancer	2.71e-06	3.55e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—CXCL8—breast cancer	2.68e-06	3.51e-05	CbGpPWpGaD
Epinastine—ADRA2A—Metabolism—PTEN—breast cancer	2.68e-06	3.5e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling by GPCR—PIK3CA—breast cancer	2.68e-06	3.5e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—CDKN1B—breast cancer	2.68e-06	3.5e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—CDKN1B—breast cancer	2.67e-06	3.49e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—MDM2—breast cancer	2.67e-06	3.48e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling by GPCR—HRAS—breast cancer	2.66e-06	3.48e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—RAF1—breast cancer	2.66e-06	3.47e-05	CbGpPWpGaD
Epinastine—HTR2A—GPCR downstream signaling—AKT1—breast cancer	2.65e-06	3.46e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—RELA—breast cancer	2.64e-06	3.46e-05	CbGpPWpGaD
Epinastine—HRH1—GPCR downstream signaling—AKT1—breast cancer	2.64e-06	3.45e-05	CbGpPWpGaD
Epinastine—CYP2D6—Metabolism—PIK3CG—breast cancer	2.64e-06	3.45e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—ERBB2—breast cancer	2.63e-06	3.44e-05	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—TP53—breast cancer	2.63e-06	3.43e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—CASP3—breast cancer	2.62e-06	3.43e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—CDKN1B—breast cancer	2.62e-06	3.42e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—IL2—breast cancer	2.62e-06	3.42e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—CASP3—breast cancer	2.62e-06	3.42e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—IL2—breast cancer	2.61e-06	3.42e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling by GPCR—IL6—breast cancer	2.6e-06	3.41e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling by GPCR—IL6—breast cancer	2.6e-06	3.4e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—PIK3CB—breast cancer	2.59e-06	3.39e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—MTOR—breast cancer	2.59e-06	3.39e-05	CbGpPWpGaD
Epinastine—ADRA1A—GPCR downstream signaling—AKT1—breast cancer	2.59e-06	3.39e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—CASP3—breast cancer	2.57e-06	3.36e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—IL2—breast cancer	2.56e-06	3.35e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—CCND1—breast cancer	2.55e-06	3.34e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling by GPCR—IL6—breast cancer	2.55e-06	3.33e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—JUN—breast cancer	2.55e-06	3.33e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—CCND1—breast cancer	2.55e-06	3.33e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—JUN—breast cancer	2.54e-06	3.32e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—COMT—breast cancer	2.54e-06	3.32e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—CTNNB1—breast cancer	2.53e-06	3.3e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—GSTP1—breast cancer	2.53e-06	3.3e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—CTNNB1—breast cancer	2.52e-06	3.3e-05	CbGpPWpGaD
Epinastine—CYP2B6—Metabolism—PTEN—breast cancer	2.51e-06	3.29e-05	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—HRAS—breast cancer	2.51e-06	3.28e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—CCND1—breast cancer	2.5e-06	3.27e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—JUN—breast cancer	2.49e-06	3.26e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—HMOX1—breast cancer	2.49e-06	3.26e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—CXCL8—breast cancer	2.49e-06	3.26e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—ITPR1—breast cancer	2.49e-06	3.25e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—MMP9—breast cancer	2.48e-06	3.24e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling by GPCR—HRAS—breast cancer	2.48e-06	3.24e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—CTNNB1—breast cancer	2.47e-06	3.24e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—MMP9—breast cancer	2.47e-06	3.23e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—CDKN1A—breast cancer	2.47e-06	3.23e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—CDKN1A—breast cancer	2.46e-06	3.22e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—PTEN—breast cancer	2.46e-06	3.22e-05	CbGpPWpGaD
Epinastine—ABCB1—Metabolism—PIK3CD—breast cancer	2.46e-06	3.22e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—PTEN—breast cancer	2.46e-06	3.21e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—CDKN1B—breast cancer	2.43e-06	3.18e-05	CbGpPWpGaD
Epinastine—ABCB1—Metabolism—ALB—breast cancer	2.43e-06	3.18e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—MMP9—breast cancer	2.43e-06	3.17e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—CDKN1A—breast cancer	2.42e-06	3.16e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—PTEN—breast cancer	2.41e-06	3.15e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—MAPK8—breast cancer	2.41e-06	3.15e-05	CbGpPWpGaD
Epinastine—ADRA2A—GPCR downstream signaling—AKT1—breast cancer	2.41e-06	3.15e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—MAPK8—breast cancer	2.4e-06	3.14e-05	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—IL6—breast cancer	2.4e-06	3.14e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling by GPCR—AKT1—breast cancer	2.4e-06	3.14e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling by GPCR—AKT1—breast cancer	2.4e-06	3.13e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—ABCB1—breast cancer	2.39e-06	3.13e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—CASP3—breast cancer	2.39e-06	3.12e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—IL2—breast cancer	2.38e-06	3.11e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling by GPCR—IL6—breast cancer	2.37e-06	3.1e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—MAPK8—breast cancer	2.36e-06	3.08e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling by GPCR—AKT1—breast cancer	2.35e-06	3.08e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—TYMS—breast cancer	2.35e-06	3.07e-05	CbGpPWpGaD
Epinastine—ABCB1—Metabolism—NOS3—breast cancer	2.32e-06	3.04e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—GSTM1—breast cancer	2.32e-06	3.04e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—NCOR1—breast cancer	2.32e-06	3.04e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—PLA2G4A—breast cancer	2.32e-06	3.04e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—CCND1—breast cancer	2.32e-06	3.04e-05	CbGpPWpGaD
Epinastine—CYP2D6—Metabolism—PIK3CD—breast cancer	2.32e-06	3.03e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—JUN—breast cancer	2.32e-06	3.03e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—CTNNB1—breast cancer	2.3e-06	3.01e-05	CbGpPWpGaD
Epinastine—CYP2D6—Metabolism—ALB—breast cancer	2.29e-06	2.99e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—SRC—breast cancer	2.28e-06	2.99e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—SRC—breast cancer	2.28e-06	2.98e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—MMP9—breast cancer	2.25e-06	2.95e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—CDKN1A—breast cancer	2.25e-06	2.94e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—PTEN—breast cancer	2.24e-06	2.93e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—SRC—breast cancer	2.24e-06	2.92e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—VEGFA—breast cancer	2.22e-06	2.91e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—GPX1—breast cancer	2.22e-06	2.91e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—VEGFA—breast cancer	2.22e-06	2.9e-05	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—AKT1—breast cancer	2.22e-06	2.9e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—STAT3—breast cancer	2.2e-06	2.88e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—CYP1A1—breast cancer	2.2e-06	2.88e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—STAT3—breast cancer	2.2e-06	2.87e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—MAPK8—breast cancer	2.19e-06	2.87e-05	CbGpPWpGaD
Epinastine—CYP2D6—Metabolism—NOS3—breast cancer	2.19e-06	2.86e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling by GPCR—AKT1—breast cancer	2.19e-06	2.86e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—ERCC2—breast cancer	2.18e-06	2.85e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—VEGFA—breast cancer	2.18e-06	2.85e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—STAT3—breast cancer	2.16e-06	2.82e-05	CbGpPWpGaD
Epinastine—ABCB1—Metabolism—PIK3CB—breast cancer	2.14e-06	2.8e-05	CbGpPWpGaD
Epinastine—ABCB1—Metabolism—PTGS2—breast cancer	2.12e-06	2.78e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—MAPK3—breast cancer	2.1e-06	2.75e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—MAPK3—breast cancer	2.1e-06	2.75e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—SRC—breast cancer	2.08e-06	2.72e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—MAPK3—breast cancer	2.06e-06	2.69e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—MTHFR—breast cancer	2.05e-06	2.68e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—MYC—breast cancer	2.05e-06	2.68e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—MYC—breast cancer	2.04e-06	2.67e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—TGFB1—breast cancer	2.04e-06	2.67e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—TGFB1—breast cancer	2.04e-06	2.66e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—VEGFA—breast cancer	2.02e-06	2.65e-05	CbGpPWpGaD
Epinastine—CYP2D6—Metabolism—PIK3CB—breast cancer	2.02e-06	2.64e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—MYC—breast cancer	2e-06	2.62e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—STAT3—breast cancer	2e-06	2.62e-05	CbGpPWpGaD
Epinastine—CYP2D6—Metabolism—PTGS2—breast cancer	2e-06	2.62e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—EGFR—breast cancer	2e-06	2.62e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—TGFB1—breast cancer	2e-06	2.61e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—EGFR—breast cancer	2e-06	2.61e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—EGFR—breast cancer	1.96e-06	2.56e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—MAPK3—breast cancer	1.91e-06	2.5e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—CAV1—breast cancer	1.89e-06	2.48e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—KRAS—breast cancer	1.89e-06	2.47e-05	CbGpPWpGaD
Epinastine—ADRA2A—Metabolism—PIK3CA—breast cancer	1.89e-06	2.47e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—KRAS—breast cancer	1.89e-06	2.47e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—MYC—breast cancer	1.86e-06	2.43e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—TGFB1—breast cancer	1.86e-06	2.43e-05	CbGpPWpGaD
Epinastine—ABCB1—Metabolism—PTEN—breast cancer	1.85e-06	2.42e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—KRAS—breast cancer	1.85e-06	2.42e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—EGFR—breast cancer	1.82e-06	2.38e-05	CbGpPWpGaD
Epinastine—CYP2B6—Metabolism—PIK3CA—breast cancer	1.77e-06	2.32e-05	CbGpPWpGaD
Epinastine—CYP2D6—Metabolism—PTEN—breast cancer	1.75e-06	2.28e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—PIK3CA—breast cancer	1.74e-06	2.27e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—PIK3CA—breast cancer	1.73e-06	2.27e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—PIK3CG—breast cancer	1.72e-06	2.25e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—KRAS—breast cancer	1.72e-06	2.25e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—PIK3CA—breast cancer	1.7e-06	2.22e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—TP53—breast cancer	1.68e-06	2.2e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—TP53—breast cancer	1.68e-06	2.19e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—TP53—breast cancer	1.65e-06	2.15e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—HRAS—breast cancer	1.61e-06	2.1e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—HRAS—breast cancer	1.6e-06	2.1e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—PIK3CA—breast cancer	1.58e-06	2.07e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—HRAS—breast cancer	1.57e-06	2.06e-05	CbGpPWpGaD
Epinastine—ADRA2A—Metabolism—AKT1—breast cancer	1.54e-06	2.02e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—IL6—breast cancer	1.54e-06	2.01e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—IL6—breast cancer	1.54e-06	2.01e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—TP53—breast cancer	1.53e-06	2e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—PIK3CD—breast cancer	1.52e-06	1.98e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—IL6—breast cancer	1.51e-06	1.97e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—ALB—breast cancer	1.5e-06	1.96e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—HRAS—breast cancer	1.46e-06	1.91e-05	CbGpPWpGaD
Epinastine—CYP2B6—Metabolism—AKT1—breast cancer	1.45e-06	1.89e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—NOS3—breast cancer	1.43e-06	1.87e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—AKT1—breast cancer	1.42e-06	1.86e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—AKT1—breast cancer	1.42e-06	1.85e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—IL6—breast cancer	1.4e-06	1.83e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—AKT1—breast cancer	1.39e-06	1.82e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—PIK3CB—breast cancer	1.32e-06	1.73e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—PTGS2—breast cancer	1.31e-06	1.71e-05	CbGpPWpGaD
Epinastine—ABCB1—Metabolism—PIK3CA—breast cancer	1.31e-06	1.71e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—AKT1—breast cancer	1.29e-06	1.69e-05	CbGpPWpGaD
Epinastine—CYP2D6—Metabolism—PIK3CA—breast cancer	1.23e-06	1.61e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—PTEN—breast cancer	1.14e-06	1.49e-05	CbGpPWpGaD
Epinastine—ABCB1—Metabolism—AKT1—breast cancer	1.07e-06	1.4e-05	CbGpPWpGaD
Epinastine—CYP2D6—Metabolism—AKT1—breast cancer	1.01e-06	1.32e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—PIK3CA—breast cancer	8.05e-07	1.05e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—AKT1—breast cancer	6.58e-07	8.6e-06	CbGpPWpGaD
